Genetic contributions to influenza virus attenuation in the rat brain
- PMID: 18444085
- DOI: 10.1080/13550280701885563
Genetic contributions to influenza virus attenuation in the rat brain
Abstract
Influenza is generally regarded as an infection of the respiratory tract; however, neurological involvement is a well-recognized, although uncommon, complication of influenza A virus infection. The authors previously described the development of a rat model for studying influenza virus infection of the central nervous system (CNS). This model was used here to study the role of virus genes in virus replication and spread in brain. In the present work, an infectious cDNA clone of the neurotoxic WSN strain of influenza virus (rWSN) was altered by site-directed mutagenesis at five loci that corresponded to changes previously shown to confer temperature sensitivity and attenuation of the A/Ann Arbor/6/60 strain (PB1Delta 391, PB1Delta 581, and PB1Delta 661; PB2Delta 265, and NPDelta 34). Whereas rWSN and its mutated derivative (mu-rWSN) replicated equally well in MDCK cells at 37 degrees C (the body temperature of rats), rWSN grew to higher titers and infection was more widespread compared to mu-rWSN in rat brain. These results demonstrate that the five mutations that confer attenuation of the A/Ann Arbor/6/60 influenza virus strain for the respiratory system also confer attenuation for the central nervous system. Further in vivo and in vitro examination of these five mutations, both individually and in combination, will likely provide important information on the role of specific virus genes in virulence and pathogenesis.
Similar articles
-
Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine.J Virol. 1995 Oct;69(10):5969-77. doi: 10.1128/JVI.69.10.5969-5977.1995. J Virol. 1995. PMID: 7666501 Free PMC article.
-
Attenuation of wild-type human influenza A virus by acquisition of the PA polymerase and matrix protein genes of influenza A/Ann Arbor/6/60 cold-adapted donor virus.J Clin Microbiol. 1985 Nov;22(5):719-25. doi: 10.1128/jcm.22.5.719-725.1985. J Clin Microbiol. 1985. PMID: 4056002 Free PMC article.
-
Evaluation of the genetic stability of the temperature-sensitive PB2 gene mutation of the influenza A/Ann Arbor/6/60 cold-adapted vaccine virus.J Virol. 1994 Dec;68(12):7684-8. doi: 10.1128/JVI.68.12.7684-7688.1994. J Virol. 1994. PMID: 7966557 Free PMC article.
-
Extending the cytoplasmic tail of the influenza a virus M2 protein leads to reduced virus replication in vivo but not in vitro.J Virol. 2008 Jan;82(2):1059-63. doi: 10.1128/JVI.01499-07. Epub 2007 Nov 7. J Virol. 2008. PMID: 17989186 Free PMC article.
-
A Conserved Residue, Tyrosine (Y) 84, in H5N1 Influenza A Virus NS1 Regulates IFN Signaling Responses to Enhance Viral Infection.Viruses. 2017 May 12;9(5):107. doi: 10.3390/v9050107. Viruses. 2017. PMID: 28498306 Free PMC article.
Cited by
-
Live Viral Vaccine Neurovirulence Screening: Current and Future Models.Vaccines (Basel). 2021 Jun 30;9(7):710. doi: 10.3390/vaccines9070710. Vaccines (Basel). 2021. PMID: 34209433 Free PMC article. Review.
-
Anti-COVID-19 drug screening: Frontier concepts and core technologies.Chin Med. 2020 Oct 28;15:115. doi: 10.1186/s13020-020-00393-z. eCollection 2020. Chin Med. 2020. PMID: 33133232 Free PMC article. Review.
-
The compensatory G88R change is essential in restoring the normal functions of influenza A/WSN/33 virus matrix protein 1 with a disrupted nuclear localization signal.J Virol. 2013 Jan;87(1):345-53. doi: 10.1128/JVI.02024-12. Epub 2012 Oct 17. J Virol. 2013. PMID: 23077315 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials